Cargando…

抗PD-L1抗体的心脏毒性及甲状腺素的救治作用实验研究

BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) such as antibodies against programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1), have shown remarkable efficacies in many subtypes of cancers. However, ICIs may also cause severe immune-related adverse events in the r...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246393/
https://www.ncbi.nlm.nih.gov/pubmed/34157799
http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.23

Ejemplares similares